Therefore, mycophenolate mofetil in combination with tacrolimus reduced serum TGF-β1 and cystatin C levels in patients with LN and showed a better and safer clinical effect than that of mycophenolate mofetil in combination with cyclophosphamide. Here, CST3 is linked to lobular neoplasia.